A novel system for remote monitoring of metabolism in animal model is proposed in this paper. The system is obtained by integrating Bio-Nano-Sensors to detect singlemetabolites, an electrochemical front-end made with offthe-shelf components, an RF communication sub-system, and an antenna of new design. The system has been calibrated and tested for continuous monitoring of four different metabolites: glucose, lactate, glutamate, and adenosine triphosphate (ATP). Tests with animal models (mice) have been conducted to investigate tissue inflammation induced by the implanted Bio-NanoSensors. The tests confirmed that our system is suitable and reliable for remote monitoring of single-metabolites in experiments with animal models.
I. INTRODUCTION
Genetically engineered mice are highly useful models for emulating human diseases and studying disease mechanisms as well as for testing therapeutic strategies [1] . Remote monitoring during the experiments assures continuous acquisition of data on soluble mediators in animal model. Remote monitoring of blood pressure in mice has been already demonstrated including remote powering of the system [2] . Although many other physiological parameters, e.g. the viscosity [3] , may be monitored by telemetry, the big challenge is the monitoring of the animal model at molecular level. Thus, it is so important to follow in time the biomarkers trend related to the disease under investigation. Continuous monitoring of humans is already in the market for glucose [4] as well as for lactate. The reliability of the technology for glucose remote monitoring has been validated up to 8 month in mice [5] and up to one year in pigs [6] . The next step will be the extension of the technology to other relevant metabolites like, for example, glutamate and ATP. Glutamate is an important neurotransmitter usually associated with brain damages [7] while ATP has been very recently associated to regulation of adaptive immune responses [8] . Carbon Nanotubes have been demonstrated to enhance the sensitivity for exogenous [9] and endogenous [10] metabolites.
The aim of the present paper is to propose the first telemetry system based on Bio-Nano-Sensors and reliable for remote and continuous single-metabolite monitoring of glucose, lactate, glutamate, and ATP in mouse models.
II THE REMOTE MONITORING SYSTEM
A. The wireless implantable system A wireless electrochemical monitoring system has been realized to assess the sensor in-vivo, as shown in Fig.1 . This embedded system responds to the constraints linked to implants in animals. The materials used to build the packaging are biocompatible and support chemical sterilization process such as ethylene oxide gas or chlorine bleach. The wireless link allows us to control and to automate the measurements at distance with a laptop computer that can be easily brought into the operation room.
B. The Implantable Body Sensor Node
The wireless monitoring system is based on the generic implantable Body Sensor Node (BSN) previously used for rheology monitoring and already described in [3, 11] . 
C. The Electrochemical Front-End
The novelty proposed in this paper for the remote monitoring system is in the electrochemical front-end. To interface the BSN to the electrochemical sensor a simple potentiostat following [12] was realized. It is based on the commercial IC MAX4039 (manufactured by Maxim integrated products) that integrates two operational amplifiers and one voltage reference (1.2 V). The IC is powered by the 3 V battery and consumes only 9 µW. The potentiostat is mounted on a circular Printed Circuit Board (PCB) of 7 mm in diameter, which is placed at the end of the BSN, just after the batteries. The potentiostat output is connected to the DSP analogue-todigital converter. Then the signal is low-pass filtered and the data are directly sent to the base station. A computer connected to the base station can display the data in real-time and save them for further analysis. The computer can also automate the measurement by enabling and disabling the BSN remotely. Then, the Bio-Nano-Sensor (see Section III) is connected to a biocompatible cable in polyurethane with silver coated wires that goes through the BSN housing to the potentiostat.
III. SINGLE-METABOLITE BIO-NANO-SENSORS A. Chemicals
Multi-Walled Carbon Nanotubes (MWCNT) were purchased in powder (90% purity) from Dropsens (Spain). Glucose oxidase from Aspergillus Niger (GOD, EC 1. 
B. Screen-Printed Electrodes
Experiments were carried out using screen-printed electrodes (SPE) from Dropsens (Spain). 
C. Preparation of the Bio-Nano-Sensors
A 40 µl volume of the MWCNT-chloroform solution was deposited by drop casting (5 µl each time) onto the working electrode and dried. Then, 20 µl of the enzyme probe were dropped onto the working electrode and stored overnight at +4 ºC, in order to allow the adsorption of the proteins onto the electrode surface. Glucose oxidase was prepared at a concentration of 15 mg/ml, lactate oxidase at 125 mg/ml, and glutamate oxidase at a concentration of 250 units/ml. For the measure of the ATP, instead, GOD and HEX were mixed in a 1:1 ratio to obtain a solution at pH 7.4 with 15 mg/ml of each protein. 20 μl of the solution were then drop cast onto the working electrode, and let dry at 4ºC overnight. The electrodes were rinsed out with Milli-Q the day after the deposition and conditioned for 10 minutes at constant potential (+650 mV) before the first use.
D. Calibration Curves and Telemetry Acquisitions
For calibration and investigation of the detection limit, electrodes were dipped into the PBS with a volume of 25 ml under stirring conditions. The electrochemical response of electrodes is investigated by chronoamperometries under aerobic conditions. The Bio-Nano-Sensors calibration has been done with electrochemical measurements acquired with the lab-electrochemical-station Versastat 3 potentiostat (Princeton Applied Technologies). The telemetry acquisitions in time have been instead acquired by using the developed telemetry system described in the previous session.
IV. IN-VITRO AND IN-VIVO TESTS
A. Calibration for Glucose, Lactate, and Glutamate Oxidases are enzymes that catalyze the transformation of metabolite (X) in metabolism product (X p ) by following the equation:
The metabolite X is glucose, lactate, and glutamate, which are catalyzed by the glucose-oxidase (GOD), the lactate-oxidase (LOD), and the glutamate-oxidase (GLOD), respectively. The reaction (1) produces the hydrogen peroxide (H 2 O 2 ) that may be oxidized: (2) and (3) are two different redox reactions, the first enabled at the electrodes interface with a typical potential of +650 mV, while the second with typical potential of +1540 mV. Of course, these potentials also depend on the metal of the electrodes. In presence of oxygen, reaction (2) is the most common used. So, for our Bio-Nano-Sensors we worked at +650 mV by following the redox of equation (2). Figs. 2, and 3, report the obtained calibration curve for two different metabolites. The good sensitivity and the ranges of concentrations are reported in Table I .
B. Calibration for ATP
In the case of the ATP monitoring, our Bio-Nano-Sensor consists of two co-immobilized enzymes: glucose oxidase and hexokinase. Both enzymes are sensitive to glucose, but with a different catalytic mechanism:
In presence of ATP, the hexokinase competes with the glucose oxidase for the substrate, and the quantity of hydrogen peroxide produced in the reaction (4) is proportionally decreased by the glucose consumption in the reaction (5) . Therefore, the ATP is detected by a decreasing of the current registered in the redox reaction (2). Fig. 3 reports the obtained calibration curve for the ATP detection and it demonstrates a good sensitivity in the reported ranges of concentrations. Table I : sensitivity and range of the Bio-Nano-Sensors
C. Telemetry Acquisitions
The metabolite is kept by the enzymes, transformed, and then released in all the reactions involving oxidases and hexokinase. This feature of reactions (1), (4), and (5) enables continuous monitoring and acquisition over time of current variation as proportionally related to the concentration of the monitored metabolites. Fig. 4 shows the continuous monitoring of glucose over a time frame of 35 minutes, while 
D. Tests with Animal Models
To check whether the Nano-Bio-Sensors has any influence on tissue homeostasis at the site of implantation, we monitored inflammatory reaction in vivo in air pouches in mice (see Fig.  6 ) in which the Nano-Bio-Sensors were implanted. The air pouch is generated by subcutaneous injection of sterile air into the back of a mouse. The resulting subcutaneous cavity has a diameter of around 1.5 cm and a height of 0.5 cm. The air pouch does not induce any relevant reaction of the tissue and provides an environment in which studying localized inflammatory phenomena by different stimuli, including the introduction of a Bio-Nano-Sensor. To study the impact of the implant, we inserted the sensor into the air pouch and analyzed the ATP concentration and neutrophils infiltration at day 7 after implantation. ATP is the source of energy for the cell. It is present at high concentration inside cells but virtually absent in extracellular fluids. Cell damage, such as the one taking place at inflammatory sites, determines the efflux of ATP from the cells and its appearance in the extracellular fluid, making it a so-called danger-associated molecular pattern. Neutrophils constitute around 50-70% of our circulating white blood cells and extravasate from blood vessels at inflammatory sites. Therefore, their presence and number is an important parameter to score inflammatory reactions. We analyzed these two parameters of inflammation in different experimental conditions. The ATP concentration in the subcutaneous microenvironment is not affected by suture. Some increase in neutrophils infiltration is detected by more invasive procedures such as performing the hole for implanting the biochip or the implantation of our Nano-BioSensors. ATP levels and neutrophils increased to a similar extent by LPS (bacterial lipopolysaccharide) injection, confirming the limited inflammation associated with sensor implantation (Fig. 7) . Nevertheless, the level of ATP induced by the implant (from 20 to 60 nM depending on different implanted sensors) is largely below the targeted range of hundreds of µM for ATP concentrations found in cell signaling [8] and relevant for anticancer treatments [13] .
VI. CONCLUSION A novel system for remote monitoring of metabolism at molecular level in translational research made with animal models has been proposed in the paper. The new proposed system integrates Bio-Nano-Sensors with electrochemical front-end for the detection, a proper transceiver, battery for the powering, and a novel antenna. The Bio-Nano-Sensors are suitable for continuous monitoring of glucose, lactate, glutamate, and ATP (four highly relevant molecules of the human metabolism). Good sensitivities were provided by carbon nanotubes used as enhancers of the electrons transfer between the probe proteins and the sensors electrode. The electrochemical front-end has been built by using out-of-theshelf components. The low-power transceiver and the antenna were especially designed for prolongation of the implantation. With the embedded non-rechargeable batteries exhibiting a total energy of 600 J, the system can be powered in stand-by for over 9 years. The tests for continuous monitoring, wireless communications, and biocompatibility demonstrated the feasibility of this technology for translational research in biomedical field with mouse models. Our in-vivo tests demonstrated mild pro-inflammatory potential at implantation site, enabling the exploitation of the proposed system for invivo monitoring. 
